{"id":"NCT02290444","sponsor":"State University of New York at Buffalo","briefTitle":"Effects of Acthar on Recovery From Cognitive Relapses in MS","officialTitle":"Effects of Adrenocorticotropic Hormone (ACTHAR Gel) on Recovery From Cognitive Relapses in Multiple Sclerosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08","primaryCompletion":"2018-11-01","completion":"2018-11-01","firstPosted":"2014-11-14","resultsPosted":"2020-04-06","lastUpdate":"2020-04-06"},"enrollment":64,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Multiple Sclerosis"],"interventions":[{"type":"DRUG","name":"Adrenocorticotropic Hormone","otherNames":["Acthar gel"]}],"arms":[{"label":"Cognitively Relapsing Patients","type":"EXPERIMENTAL"},{"label":"Stable Multiple Sclerosis Patients","type":"NO_INTERVENTION"}],"summary":"The purpose of this study is to evaluate the effect of a medication called Acthar on recovery from multiple sclerosis-related relapses that impact cognition.","primaryOutcome":{"measure":"Change From Baseline on the Symbol Digit Modalities Test (SDMT)","timeFrame":"Day 0 and Day 90","effectByArm":[{"arm":"Cognitively Relapsing Patients","deltaMin":44.6,"sd":13.9},{"arm":"Stable Multiple Sclerosis Patients","deltaMin":58.5,"sd":13.9}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["16626751","18829629","9576548","17294621","17623735","20084515","21556031","17613607","11724451","11594918","21384163","12607150","16981607","866038","17613599","21486517","11034713","17920543","17920542","10467383","2027484","12617275","6685237","1200192"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":25},"commonTop":[]}}